Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
NAYA Biosciences ( (NAYA) ) has provided an announcement.
On January 14, 2025, NAYA Biosciences completed a public offering of 13,615,171 units, raising approximately $9.5 million. The proceeds will be used for multiple strategic purposes, including funding the purchase of the Wisconsin Fertility Institute, redeeming preferred stock, addressing debt obligations, and supporting clinical trials and corporate activities. The company also received a compliance notice from Nasdaq regarding the failure to hold an annual meeting of shareholders but plans to address it by March 2025.
More about NAYA Biosciences
NAYA Biosciences is a life science portfolio company dedicated to developing breakthrough treatments in oncology, autoimmune diseases, and women’s health. Utilizing a hub & spoke model, it combines scalable commercial revenues with innovative clinical-stage therapeutics, featuring assets like bifunctional antibodies for various cancers and autoimmune conditions.
YTD Price Performance: -45.24%
Average Trading Volume: 260,940
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.24M
See more data about NAYA stock on TipRanks’ Stock Analysis page.
